Search Within

MSK Grad Students

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (519)
  2. Journal Article (329)
  3. Review (40)
  4. Miscellaneous (16)
  5. Research Letter (15)
  6. Editorial (14)
  7. Correspondence (12)
  8. Conference Paper (4)
  9. Book Section (3)
  10. Guidelines (3)
Groups
  1. CTCR Scholars (955)
  2. Master of Science in Clinical and Translational Cancer Research (955)
  3. Department of Medicine (853)
  4. Hematologic Malignancies, Division of (651)
  5. Center for Hematologic Malignancies (630)
  6. Survivorship Research (578)

More Groups

People
  1. Sergio Giralt (378)
  2. Miguel-Angel Perales (356)
  3. Parastoo Dahi (294)
  4. Sean Devlin (265)
  5. Doris Ponce (254)
  6. Roni Tamari (208)

More People

Years
  1. 2025 (41)
  2. 2024 (109)
  3. 2023 (140)
  4. 2022 (121)
  5. 2021 (104)
  6. 2020 (119)

More Years

Publications
  1. Blood (191)
  2. Biology of Blood and Marrow Transplantation (153)
  3. Journal of Clinical Oncology (79)
  4. Annals of Surgical Oncology (78)
  5. Bone Marrow Transplantation (55)
  6. Transplantation and Cellular Therapy (42)

More Publications

Publishers
  1. American Society of Hematology (223)
  2. Elsevier Inc. (219)
  3. Springer (90)
  4. American Society of Clinical Oncology (87)
  5. Nature Publishing Group (82)
  6. American Association for Cancer Research (29)

More Publishers

Results (955)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Despite increasing size of unrelated donor (URD) registries and the global cord blood (CB) inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K.; Dahi, P. B.; Devlin, S.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A novel intermediate intensity conditioning regimen achieves high rates of long-term outpatient progression-free survival offsetting the disadvantage of early post-transplant complications in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Politikos, I.; Devlin, S.; Yoo, Y.; Mazis, C.; Maloy, M. A.; Scaradavou, A.; Dahi, P. B.; Perales, M.; Giralt, S.; Ponce, D. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P. B.; Devlin, S.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M.; Giralt, S. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Prognostic factors of CLL patients undergoing reduced intensity allogeneic hematopoietic stem cell transplantation in the immunochemotherapy era
    Meeting Abstract

    Lahoud, O. B.; Hilden, P.; Maloy, M. A.; Dahi, P. B.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S. A.; Sauter, C. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Carfilzomib plus high dose melphalan conditioning prior to autologous hematopoietic cell transplantation followed by carfilzomib maintenance in patients with relapsed multiple myeloma
    Meeting Abstract

    Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Salzman, D.; Saad, A.; Innis-Shelton, R.; Hamadani, M.; Tamari, R.; Godby, K. N.; more...
    Blood (2016)

    Fulltext@MSK | Save